Literature DB >> 29107053

Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.

Mariet Allen1, Xue Wang2, Jeremy D Burgess1, Jens Watzlawik1, Daniel J Serie2, Curtis S Younkin3, Thuy Nguyen1, Kimberly G Malphrus1, Sarah Lincoln1, Minerva M Carrasquillo1, Charlotte Ho1, Paramita Chakrabarty4, Samantha Strickland1, Melissa E Murray1, Vivek Swarup5, Daniel H Geschwind5, Nicholas T Seyfried6, Eric B Dammer7, James J Lah8, Allan I Levey8, Todd E Golde4, Cory Funk9, Hongdong Li9, Nathan D Price9, Ronald C Petersen10, Neill R Graff-Radford11, Steven G Younkin1, Dennis W Dickson1, Julia R Crook2, Yan W Asmann2, Nilüfer Ertekin-Taner12.   

Abstract

INTRODUCTION: Comparative transcriptome analyses in Alzheimer's disease (AD) and other neurodegenerative proteinopathies can uncover both shared and distinct disease pathways.
METHODS: We analyzed 940 brain transcriptomes including patients with AD, progressive supranuclear palsy (PSP; a primary tauopathy), and control subjects.
RESULTS: We identified transcriptional coexpression networks implicated in myelination, which were lower in PSP temporal cortex (TCX) compared with AD. Some of these associations were retained even after adjustments for brain cell population changes. These TCX myelination network structures were preserved in cerebellum but they were not differentially expressed in cerebellum between AD and PSP. Myelination networks were downregulated in both AD and PSP, when compared with control TCX samples. DISCUSSION: Downregulation of myelination networks may underlie both PSP and AD pathophysiology, but may be more pronounced in PSP. These data also highlight conservation of transcriptional networks across brain regions and the influence of cell type changes on these networks.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cerebellum; Coexpression networks; Myelination; Progressive supranuclear palsy; Proteinopathies; Temporal cortex; Transcriptome

Mesh:

Year:  2017        PMID: 29107053      PMCID: PMC5866744          DOI: 10.1016/j.jalz.2017.09.012

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  46 in total

Review 1.  Immune attack: the role of inflammation in Alzheimer disease.

Authors:  Frank L Heppner; Richard M Ransohoff; Burkhard Becher
Journal:  Nat Rev Neurosci       Date:  2015-06       Impact factor: 34.870

2.  A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.

Authors:  Nicholas T Seyfried; Eric B Dammer; Vivek Swarup; Divya Nandakumar; Duc M Duong; Luming Yin; Qiudong Deng; Tram Nguyen; Chadwick M Hales; Thomas Wingo; Jonathan Glass; Marla Gearing; Madhav Thambisetty; Juan C Troncoso; Daniel H Geschwind; James J Lah; Allan I Levey
Journal:  Cell Syst       Date:  2016-12-15       Impact factor: 10.304

Review 3.  Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond.

Authors:  Elise Cuyvers; Kristel Sleegers
Journal:  Lancet Neurol       Date:  2016-07       Impact factor: 44.182

Review 4.  Protein aggregate formation in oligodendrocytes: tau and the cytoskeleton at the intersection of neuroprotection and neurodegeneration.

Authors:  Christiane Richter-Landsberg
Journal:  Biol Chem       Date:  2016-03       Impact factor: 3.915

5.  Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.

Authors:  Minerva M Carrasquillo; Fanggeng Zou; V Shane Pankratz; Samantha L Wilcox; Li Ma; Louise P Walker; Samuel G Younkin; Curtis S Younkin; Linda H Younkin; Gina D Bisceglio; Nilufer Ertekin-Taner; Julia E Crook; Dennis W Dickson; Ronald C Petersen; Neill R Graff-Radford; Steven G Younkin
Journal:  Nat Genet       Date:  2009-01-11       Impact factor: 38.330

6.  A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging.

Authors:  Jeremy A Miller; Michael C Oldham; Daniel H Geschwind
Journal:  J Neurosci       Date:  2008-02-06       Impact factor: 6.167

7.  Removing technical variability in RNA-seq data using conditional quantile normalization.

Authors:  Kasper D Hansen; Rafael A Irizarry; Zhijin Wu
Journal:  Biostatistics       Date:  2012-01-27       Impact factor: 5.899

8.  Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.

Authors:  Fanggeng Zou; High Seng Chai; Curtis S Younkin; Mariet Allen; Julia Crook; V Shane Pankratz; Minerva M Carrasquillo; Christopher N Rowley; Asha A Nair; Sumit Middha; Sooraj Maharjan; Thuy Nguyen; Li Ma; Kimberly G Malphrus; Ryan Palusak; Sarah Lincoln; Gina Bisceglio; Constantin Georgescu; Naomi Kouri; Christopher P Kolbert; Jin Jen; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg; Ronald C Petersen; Neill R Graff-Radford; Dennis W Dickson; Steven G Younkin; Nilüfer Ertekin-Taner
Journal:  PLoS Genet       Date:  2012-06-07       Impact factor: 5.917

9.  Alternative Approaches in Gene Discovery and Characterization in Alzheimer's Disease.

Authors:  Nilüfer Ertekin-Taner; Phillip L De Jager; Lei Yu; David A Bennett
Journal:  Curr Genet Med Rep       Date:  2013-01-22

Review 10.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

View more
  50 in total

1.  Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology.

Authors:  Hyun-Sik Yang; Charles C White; Hans-Ulrich Klein; Lei Yu; Christopher Gaiteri; Yiyi Ma; Daniel Felsky; Sara Mostafavi; Vladislav A Petyuk; Reisa A Sperling; Nilüfer Ertekin-Taner; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Neuron       Date:  2020-06-10       Impact factor: 17.173

2.  RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

Authors:  Isaac Bishof; Eric B Dammer; Duc M Duong; Sean R Kundinger; Marla Gearing; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  J Biol Chem       Date:  2018-05-25       Impact factor: 5.157

3.  Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer's disease.

Authors:  Samuel Morabito; Emily Miyoshi; Neethu Michael; Vivek Swarup
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

4.  APOE ε4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease.

Authors:  Annah M Moore; Emily Mahoney; Logan Dumitrescu; Philip L De Jager; Mary Ellen I Koran; Vladislav A Petyuk; Renã As Robinson; Douglas M Ruderfer; Nancy J Cox; Julie A Schneider; David A Bennett; Angela L Jefferson; Timothy J Hohman
Journal:  Neurobiol Aging       Date:  2019-11-05       Impact factor: 4.673

5.  Disruption of a RAC1-centred network is associated with Alzheimer's disease pathology and causes age-dependent neurodegeneration.

Authors:  Masataka Kikuchi; Michiko Sekiya; Norikazu Hara; Akinori Miyashita; Ryozo Kuwano; Takeshi Ikeuchi; Koichi M Iijima; Akihiro Nakaya
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

6.  Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

Authors:  Cyril Pottier; Yingxue Ren; Ralph B Perkerson; Matt Baker; Gregory D Jenkins; Marka van Blitterswijk; Mariely DeJesus-Hernandez; Jeroen G J van Rooij; Melissa E Murray; Elizabeth Christopher; Shannon K McDonnell; Zachary Fogarty; Anthony Batzler; Shulan Tian; Cristina T Vicente; Billie Matchett; Anna M Karydas; Ging-Yuek Robin Hsiung; Harro Seelaar; Merel O Mol; Elizabeth C Finger; Caroline Graff; Linn Öijerstedt; Manuela Neumann; Peter Heutink; Matthis Synofzik; Carlo Wilke; Johannes Prudlo; Patrizia Rizzu; Javier Simon-Sanchez; Dieter Edbauer; Sigrun Roeber; Janine Diehl-Schmid; Bret M Evers; Andrew King; M Marsel Mesulam; Sandra Weintraub; Changiz Geula; Kevin F Bieniek; Leonard Petrucelli; Geoffrey L Ahern; Eric M Reiman; Bryan K Woodruff; Richard J Caselli; Edward D Huey; Martin R Farlow; Jordan Grafman; Simon Mead; Lea T Grinberg; Salvatore Spina; Murray Grossman; David J Irwin; Edward B Lee; EunRan Suh; Julie Snowden; David Mann; Nilufer Ertekin-Taner; Ryan J Uitti; Zbigniew K Wszolek; Keith A Josephs; Joseph E Parisi; David S Knopman; Ronald C Petersen; John R Hodges; Olivier Piguet; Ethan G Geier; Jennifer S Yokoyama; Robert A Rissman; Ekaterina Rogaeva; Julia Keith; Lorne Zinman; Maria Carmela Tartaglia; Nigel J Cairns; Carlos Cruchaga; Bernardino Ghetti; Julia Kofler; Oscar L Lopez; Thomas G Beach; Thomas Arzberger; Jochen Herms; Lawrence S Honig; Jean Paul Vonsattel; Glenda M Halliday; John B Kwok; Charles L White; Marla Gearing; Jonathan Glass; Sara Rollinson; Stuart Pickering-Brown; Jonathan D Rohrer; John Q Trojanowski; Vivianna Van Deerlin; Eileen H Bigio; Claire Troakes; Safa Al-Sarraj; Yan Asmann; Bruce L Miller; Neill R Graff-Radford; Bradley F Boeve; William W Seeley; Ian R A Mackenzie; John C van Swieten; Dennis W Dickson; Joanna M Biernacka; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2019-02-09       Impact factor: 17.088

7.  miR-142-3p regulates cortical oligodendrocyte gene co-expression networks associated with tauopathy.

Authors:  Jason D Hinman; Kathie J Ngo; Deborah Kim; Cidi Chen; Carmela R Abraham; Mohsen Ghanbari; M Arfan Ikram; Steven A Kushner; Riki Kawaguchi; Giovanni Coppola; Kerstin Goth; Saverio Bellusci; Israel Hernandez; Kenneth S Kosik; Brent L Fogel
Journal:  Hum Mol Genet       Date:  2021-03-25       Impact factor: 6.150

8.  Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer's disease.

Authors:  Joseph S Reddy; Mariet Allen; Charlotte C G Ho; Stephanie R Oatman; Özkan İş; Zachary S Quicksall; Xue Wang; Jiangli Jin; Tulsi A Patel; Troy P Carnwath; Thuy T Nguyen; Kimberly G Malphrus; Sarah J Lincoln; Minerva M Carrasquillo; Julia E Crook; Takahisa Kanekiyo; Melissa E Murray; Guojun Bu; Dennis W Dickson; Nilüfer Ertekin-Taner
Journal:  Acta Neuropathol Commun       Date:  2021-05-21       Impact factor: 7.578

9.  Non-coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in women.

Authors:  Elizabeth E Blue; Timothy A Thornton; Charles Kooperberg; Simin Liu; Jean Wactawski-Wende; JoAnn Manson; Lew Kuller; Kathleen Hayden; Alexander P Reiner
Journal:  Alzheimers Dement       Date:  2020-09-23       Impact factor: 21.566

10.  Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer's disease.

Authors:  Samuel Morabito; Emily Miyoshi; Neethu Michael; Saba Shahin; Alessandra Cadete Martini; Elizabeth Head; Justine Silva; Kelsey Leavy; Mari Perez-Rosendahl; Vivek Swarup
Journal:  Nat Genet       Date:  2021-07-08       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.